These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2309676)

  • 1. On-demand treatment for duodenal ulcers: has its time come?
    Freston JW
    Am J Gastroenterol; 1990 Mar; 85(3):241-2. PubMed ID: 2309676
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment of duodenal ulcer.
    Wormsley KG
    Postgrad Med J; 1988; 64 Suppl 1():47-53. PubMed ID: 3047725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute treatment of duodenal ulcer. Results of an open multicenter study with famotidine nocte].
    Schönekäs H
    Fortschr Med; 1988 May; 106(14):304-6. PubMed ID: 3042560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration].
    Bonardelli P; Fujita Y; Fujita R; Sugata F
    Clin Ter; 1987 Aug; 122(3):183-7. PubMed ID: 2904317
    [No Abstract]   [Full Text] [Related]  

  • 6. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
    Schütze K; Hentschel E
    Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH; Buttigieg RJ; Iseli A
    Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continued gastric acid inhibitory therapy after Helicobacter eradication?].
    Mössner J
    Internist (Berl); 1997 Nov; 38(11):1105-7. PubMed ID: 9453962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastrin-17 level in the omeprazole treatment of duodenal ulcer].
    Belov DF; Maksimova ID; Ponomarev AA; Loginov AF
    Eksp Klin Gastroenterol; 2005; (6):28-32, 112. PubMed ID: 17378383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
    Kimmig JM
    Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the efficacy of monotherapy with cimetidine and combined treatment of the recurrent duodenal ulcer].
    Grigor'ev PIa; Khar'kovskiĭ NN; El'tsova GB; Prianishnikova AS; Iakovenko EP
    Ter Arkh; 1983; 55(9):107-10. PubMed ID: 6635966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
    Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralfate effervescent tablet: treatment of peptic ulcer disease and change in serum aluminium concentration.
    Schütze K; Hentschel E; Happonen P; Akkila J
    Hepatogastroenterology; 1995 Jul; 42(3):240-5. PubMed ID: 7590572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
    Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
    Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
    [No Abstract]   [Full Text] [Related]  

  • 17. One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori.
    Sung JJ; Chung SC; Ling TK; Yung MY; Cheng AF; Hosking SW; Li AK
    Am J Gastroenterol; 1994 Feb; 89(2):199-202. PubMed ID: 8304303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer].
    Tsimmerman IaS; Shchetkin DI
    Klin Med (Mosk); 2002; 80(1):48-53. PubMed ID: 11855320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].
    Orziev ZM; Nurbaev FE; Rakhimova GSh
    Klin Med (Mosk); 2003; 81(6):48-9. PubMed ID: 12875192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective prevention of recurrent duodenal ulcer with supplementary antibiotic therapy].
    Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 1993 Dec; 155(49):4020-1. PubMed ID: 8273220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.